Arkolith/Insider Trading/UTHR/Form 4

Rothblatt Martine A

Chairperson & CEO, DirectorUNITED THERAPEUTICS Corp (UTHR) · full profile →Form 4 · filed Jul 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.2M
Net Open-Market Flow
-$5.2M
Transactions
12
11 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 10, 2026Option exercise(M)10K$135.42$1.3M50K
Jul 10, 2026Sell(S)600$540.37$324K49K
Jul 10, 2026Sell(S)970$541.47$525K48K
Jul 10, 2026Sell(S)2K$542.49$1.0M47K
Jul 10, 2026Sell(S)676$543.34$367K46K
Jul 10, 2026Sell(S)364$544.54$198K46K
Jul 10, 2026Sell(S)2K$545.54$831K44K
Jul 10, 2026Sell(S)1K$546.42$786K43K
Jul 10, 2026Sell(S)2K$547.17$863K41K
Jul 10, 2026Sell(S)400$548.44$219K41K
Jul 10, 2026Sell(S)80$553.47$44K41K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 10, 2026Option exercise(M)10K—$021K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001106578-26-000096) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML